1. Home
  2. CYTK vs DECK Comparison

CYTK vs DECK Comparison

Compare CYTK & DECK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

SELL

Current Price

$54.70

Market Cap

10.7B

Sector

Health Care

ML Signal

SELL

Logo Deckers Outdoor Corporation

DECK

Deckers Outdoor Corporation

HOLD

Current Price

$87.30

Market Cap

12.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
DECK
Founded
1997
1973
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Shoe Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.7B
12.4B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
CYTK
DECK
Price
$54.70
$87.30
Analyst Decision
Buy
Hold
Analyst Count
22
27
Target Price
★ $107.39
$96.74
AVG Volume (30 Days)
1.6M
★ 3.2M
Earning Date
11-04-2026
10-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 10.90
EPS
N/A
★ 3.24
Revenue
$13,368,000.00
★ $5,472,296,000.00
Revenue This Year
$79.67
$4.33
Revenue Next Year
$172.23
$5.81
P/E Ratio
★ N/A
$27.50
Revenue Growth
N/A
★ 9.76
52 Week Low
$58.25
$77.37
52 Week High
$88.31
$122.29

Technical Indicators

Market Signals
Indicator
CYTK
DECK
Relative Strength Index (RSI) 52.28 63.58
Support Level $63.96 $77.64
Resistance Level $66.93 $93.09
Average True Range (ATR) 2.04 2.91
MACD 0.50 0.43
Stochastic Oscillator 86.71 88.92

Price Performance

Historical Comparison
CYTK
DECK

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About DECK Deckers Outdoor Corporation

Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2026, Ugg and Hoka accounted for 50% and 47% of total sales, respectively. The firm also markets a niche sandal brand Teva. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has more than 200 company-operated stores, about half of which are outlets. The firm generated 58% of its fiscal 2026 sales in the United States.

Share on Social Networks: